CAGRILINTIDE MECHANISM
How Does Cagrilintide Work? The Amylin Pathway
A long-acting amylin analog acting on satiety
How does cagrilintide work? Cagrilintide is a long-acting analog of amylin, a hormone your body naturally releases alongside insulin. It works through a different pathway than the GLP-1 medications that dominate current weight management. For its regulatory status, see the cagrilintide regulatory-status page.
The Amylin Pathway
Amylin is co-secreted with insulin after eating and helps signal fullness, slows gastric emptying, and influences appetite. Cagrilintide activates amylin (and related calcitonin) receptors, extending that satiety signaling with a long-acting design.
Source: Peer-reviewed reporting on the cagrilintide/amylin mechanism.
Why It's Studied With GLP-1
Because amylin and GLP-1 act through separate but complementary appetite pathways, cagrilintide is often studied together with semaglutide (as CagriSema) — the idea being that two different mechanisms may add up.
Frequently Asked Questions
Is cagrilintide a GLP-1 drug?
No. It's an amylin analog, which is a different appetite pathway from GLP-1.
The Bottom Line
Cagrilintide works by mimicking amylin to extend satiety signaling through a non-GLP-1 pathway — that amylin mechanism is the answer to how cagrilintide works.
This article is for general educational purposes only. It is not medical advice and should not be used to diagnose, treat, or make decisions about any health condition or medication.
Primary Sources
- Peer-reviewed reporting on the cagrilintide/amylin mechanism
- Novo Nordisk clinical program disclosures
Wellness should feel clear, personal, and supported.
Start with education, ask the right questions, and take the next step with confidence.
Get in touch →